Crossmark

Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease

Crossref DOI link: https://doi.org/10.1007/s00415-022-11089-9

Published Online: 2022-04-05

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moog, Tatum M.

McCreary, Morgan

Wilson, Andrew

Stanley, Thomas

Yu, Fang F.

Pinho, Marco

Guo, Xiaohu

Okuda, Darin T. https://orcid.org/0000-0002-6499-1523
License Information

Text and Data Mining valid from 2022-04-05

Version of Record valid from 2022-04-05
More Information

Article History

Received: 22 January 2022

Revised: 16 March 2022

Accepted: 17 March 2022

First Online: 5 April 2022

Declarations

:

: D.O. received personal compensation for consulting and advisory services from Biogen, Celgene/Bristol Myers Squibb, EMD Serono, Genentech, Genzyme, Janssen Pharmaceuticals, Novartis, Osmotica Pharmaceuticals, RVL Pharmaceuticals, Inc., TG Therapeutics, Viela Bio, Inc., and research support from Biogen and EMD Serono/Merck. Dr. Okuda received royalties for intellectual property licensed by The Board of Regents of The University of Texas System. T.M., M.M., A.W., T.S., F.Y., M.P., and X.G. have no disclosures.

Document is current

Any future updates will be listed below